ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug Authority (SFDA) has granted approval of ANKTIVA® (nogapendekin alfa inbakicept) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback